Patent · US Active

Kv1.5 potassium channel inhibitors

US7803827B2 · kind B2 · utility

0Cited by
2References
69Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2008
Grant dateSep 28, 2010
Priority date
Expiry dateNov 6, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents. The present invention further relates to compositions comprising said Kv1.5 potassium channel inhibitors, and to methods for treating cardiac arrhythmia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.